Treatment of Painful menstruation with Ajwain khurasani

Management of primary dysmenorrhea (usre tams) with Ajwain khurasani in comparison with Mefenamic acid - Nil

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/05/066869

Enrollment

Registered

2024-05-06

Start date

Unknown

Completion date

Unknown

Last updated

2024-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N944- Primary dysmenorrhea

Interventions

Intervention1: ajwain khurasani (Hyoscyamus niger) control group Mefenamic acid: Group A: test group will be given joshanda of ajwain khurasani 15ml bd with honey(2 days before the onset of menstruati

Eligibility

Inclusion criteria

Inclusion criteria: . Patient with regular periods . Painful menstruation Age group 13-30 years

Exclusion criteria

Exclusion criteria: pregnant women use of intrauterine device/oral contraceptive pills organic pelvic pathology women with systemic illness women with allergic/ hypersensitive to NSAIDs

Design outcomes

Primary

Measure	Time frame
visual analogue scaleTimepoint: 3 consecutive menstrual cycle	—

Secondary

Measure	Time frame
efficacy of test & control drug on associated symptoms fatigue, headache, nausea & vomitingTimepoint: for 3 consecutive menstrual cycle	—

Countries

India

Contacts

Public ContactDr. M.N.Nasrina Begum

Govt.Nizamia Tibbi College and Hospital

drssntc@gmail.com9908624090

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026